216 related articles for article (PubMed ID: 31485649)
21. Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo.
Le Gal FA; Avril MF; Bosq J; Lefebvre P; Deschemin JC; Andrieu M; Dore MX; Guillet JG
J Invest Dermatol; 2001 Dec; 117(6):1464-70. PubMed ID: 11886510
[TBL] [Abstract][Full Text] [Related]
22. HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1.
Lang KS; Caroli CC; Muhm A; Wernet D; Moris A; Schittek B; Knauss-Scherwitz E; Stevanovic S; Rammensee HG; Garbe C
J Invest Dermatol; 2001 Jun; 116(6):891-7. PubMed ID: 11407977
[TBL] [Abstract][Full Text] [Related]
23. Oxidative stress-induced overexpression of miR-25: the mechanism underlying the degeneration of melanocytes in vitiligo.
Shi Q; Zhang W; Guo S; Jian Z; Li S; Li K; Ge R; Dai W; Wang G; Gao T; Li C
Cell Death Differ; 2016 Mar; 23(3):496-508. PubMed ID: 26315342
[TBL] [Abstract][Full Text] [Related]
24. First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi.
van Geel NA; Mollet IG; De Schepper S; Tjin EP; Vermaelen K; Clark RA; Kupper TS; Luiten RM; Lambert J
Pigment Cell Melanoma Res; 2010 Jun; 23(3):375-84. PubMed ID: 20370855
[TBL] [Abstract][Full Text] [Related]
25. Regulatory T Cells Require CCR6 for Skin Migration and Local Suppression of Vitiligo.
Essien KI; Katz EL; Strassner JP; Harris JE
J Invest Dermatol; 2022 Dec; 142(12):3158-3166.e7. PubMed ID: 35777498
[TBL] [Abstract][Full Text] [Related]
26. Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo.
Yang L; Wei Y; Sun Y; Shi W; Yang J; Zhu L; Li M
Acta Derm Venereol; 2015 Jul; 95(6):664-70. PubMed ID: 25721262
[TBL] [Abstract][Full Text] [Related]
27. Treatment update for vitiligo based on autoimmune inhibition and melanocyte protection.
Xie B; Zhu Y; Shen Y; Xu W; Song X
Expert Opin Ther Targets; 2023 Mar; 27(3):189-206. PubMed ID: 36947026
[TBL] [Abstract][Full Text] [Related]
28. New insight into the role of exosomes in vitiligo.
Wong PM; Yang L; Yang L; Wu H; Li W; Ma X; Katayama I; Zhang H
Autoimmun Rev; 2020 Nov; 19(11):102664. PubMed ID: 32942029
[TBL] [Abstract][Full Text] [Related]
29. Metabo-miR: miR-211 Regulates Mitochondrial Energy Metabolism in Vitiligo.
Spiegelman VS; Elcheva IA
J Invest Dermatol; 2017 Sep; 137(9):1828-1830. PubMed ID: 28843294
[TBL] [Abstract][Full Text] [Related]
30. Histamine effect on melanocyte proliferation and vitiliginous keratinocyte survival.
Kim NH; Lee AY
Exp Dermatol; 2010 Dec; 19(12):1073-9. PubMed ID: 21054556
[TBL] [Abstract][Full Text] [Related]
31. Regulatory T cells in vitiligo: Implications for pathogenesis and therapeutics.
Dwivedi M; Kemp EH; Laddha NC; Mansuri MS; Weetman AP; Begum R
Autoimmun Rev; 2015 Jan; 14(1):49-56. PubMed ID: 25308528
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of allogeneic cytotoxic T cell (CD8
Kang N; Toyofuku WM; Yang X; Scott MD
Acta Biomater; 2017 Jul; 57():146-155. PubMed ID: 28442414
[TBL] [Abstract][Full Text] [Related]
33. Elevated expression of miR-155 is associated with the differentiation of CD8+ T cells in patients with HIV-1.
Jin C; Cheng L; Lu X; Xie T; Wu H; Wu N
Mol Med Rep; 2017 Aug; 16(2):1584-1589. PubMed ID: 28627655
[TBL] [Abstract][Full Text] [Related]
34. Apoptosis in feathers of Smyth line chickens with autoimmune vitiligo.
Wang X; Erf GF
J Autoimmun; 2004 Feb; 22(1):21-30. PubMed ID: 14709410
[TBL] [Abstract][Full Text] [Related]
35. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
[TBL] [Abstract][Full Text] [Related]
36. Melanocyte-specific CD49a
Yokoi K; Watanabe R; Kume M; Yamane S; Tanaka A; Fujimoto M; Tanemura A
J Dermatol; 2023 May; 50(5):710-714. PubMed ID: 36514908
[TBL] [Abstract][Full Text] [Related]
37. Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.
Palermo B; Campanelli R; Garbelli S; Mantovani S; Lantelme E; Brazzelli V; Ardigó M; Borroni G; Martinetti M; Badulli C; Necker A; Giachino C
J Invest Dermatol; 2001 Aug; 117(2):326-32. PubMed ID: 11511311
[TBL] [Abstract][Full Text] [Related]
38. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.
Goldstein NB; Koster MI; Hoaglin LG; Spoelstra NS; Kechris KJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
J Invest Dermatol; 2015 Aug; 135(8):2068-2076. PubMed ID: 25822579
[TBL] [Abstract][Full Text] [Related]
39. Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity.
Lin X; Tian H; Xianmin M
Med Hypotheses; 2011 Mar; 76(3):339-42. PubMed ID: 21075543
[TBL] [Abstract][Full Text] [Related]
40. A preliminary study of growth characteristics of melanocytes co-cultured with keratinocytes in vitro.
Zhang C; Zhou L; Huang J; Mei X; Wu Z; Shi W
J Cell Biochem; 2018 Jul; 119(7):6173-6180. PubMed ID: 29637612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
